007720 — Daemyung SonoSeason Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩51bn
- -KR₩15bn
- KR₩160bn
- 35
- 52
- 33
- 31
2019 December 31st | R2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Interim Report | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 156,120 | 143,297 | 124,732 | 97,287 | 96,957 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 30,660 | 20,984 | 17,433 | 17,686 | 27,383 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 202,786 | 175,132 | 151,054 | 128,478 | 134,613 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 5,951 | 4,010 | 3,237 | 4,140 | 3,629 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 243,679 | 212,770 | 190,515 | 168,960 | 168,787 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 73,677 | 48,929 | 49,419 | 50,425 | 51,085 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 78,031 | 52,836 | 53,488 | 53,937 | 53,895 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 165,648 | 159,934 | 137,027 | 115,023 | 114,892 |
Total Liabilities & Shareholders' Equity | 243,679 | 212,770 | 190,515 | 168,960 | 168,787 |
Total Common Shares Outstanding |